Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19

      00:00 - 00:00  |  Presenter: Laia Fernández-Mañas

      • Abstract

      Loading...

    • +

      P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period

      00:00 - 00:00  |  Presenter: Teresa Gorría

      • Abstract

      Loading...

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P84.03 - GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

      00:00 - 00:00  |  Presenter: Nir Peled

      • Abstract

      Loading...

    • +

      P84.14 - Identification of Mechanisms of Resistance to ALK Inhibitors. Next-Generation Sequencing-Based Liquid Biopsy Profiling.

      00:00 - 00:00  |  Presenter: Atocha Romero

      • Abstract

      Loading...

  • +

    OA01 - Established Drugs in Special Populations and New Drugs in Established Populations

    • 09:15 - 10:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      OA01.01 - Chair

      09:15 - 09:15  |  Presenter: Noemi Reguart

      • Abstract

      No abstract available for this presentation

  • +

    OA02 - Updates in Locally Advanced NSCLC

    • 09:15 - 10:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Locoregional and Oligometastatic Disease
    • +

      OA02.03 - Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799

      09:15 - 09:25  |  Presenter: Martin Reck

      • Abstract

      Loading...

  • +

    MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Early Stage/Localized Disease
    • +

      MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

      15:55 - 16:00  |  Presenter: Roxana Reyes

      • Abstract

      Loading...